Adverum Biotechnologies Inc (NASDAQ:ADVM)

0.8691
Delayed Data
As of 3:59pm ET
 +0.0291 / +3.46%
Today’s Change
0.80
Today|||52-Week Range
3.86
-50.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues2.3M1.5M1.8M1.6M
 
 
 
 
 
Depreciation And Amortization812.0K1.6M2.1M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses46.9M52.2M58.1M72.9M
 
 
 
 
 
Research And Development25.6M32.0M40.3M50.1M
 
 
 
 
 
Total Operating Expenses47.7M53.9M60.2M74.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-45.4M-52.4M-58.4M-73.1M
 
 
 
 
 
Extraordinary Charge-2.6M-63.2M-1.0M-5.2M
 
 
 
 
 
Other Expenses370.0K762.0K2.7M4.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-47.6M-114.8M-56.7M-73.9M
 
 
 
 
 
Income Taxes-100.0K-1.1M-507.0K-1.3M
 
 
 
 
 
Net Income-47.5M-113.7M-56.1M-72.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.5M36.2M43.7M61.4M
 
 
 
 
 
Shares To Calculate EPS Diluted25.5M36.2M43.7M61.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.86-$3.14-$1.29-$1.18
 
 
 
 
 
EPS Diluted-$1.86-$3.14-$1.29-$1.18